Invitation Programme WFSBP 2017

31 / 48

31
Symposia / Preliminary Scientific Programme
WFSBP 2017
S-53-004
Non-coding RNAs: Novel epigenetic regulators in
suicidal behavior
Yogesh Dwivedi, USA
T51: PSYCHOPHARMACOLOGY
S-54
17:00–18:30
Lithium as a neuroprotective agent: When and how?
Chair: Galila Agam, Israel
Co-Chair: Changlian Zhu, People's Republic of China
S-54-001
In vivo lithium-induced augments mitochondrial function,
reduces neuroinflammation and increases autophagy
Galila Agam, Israel
S-54-002
Lithium as a novel approach to treat developing brain
injury
Changlian Zhu, China, People’s Republic of
S-54-003
Hui Zhang, USA
S-54-004
Francoise Croute, France
T23: MOOD STABILISERS: BASIC/CLINICAL
S-55
17:00–18:30
Rediscovering Lithium
Chair: David Taylor, United Kingdom
Co-Chair: Jonathan Meyer, USA
S-55-001
The evidence for Lithium's antisuicide properties and
impact on mortality
Jimmi Nielsen, Denmark
S-55-002
The evidence for Lithium's neuroprotective properties
Barrat Luft, United Kingdom
S-55-003
What is the risk for end stage renal disease with Lithium:
A sophisticated review
Ursula Werneke, Sweden
M. Ott, E. Salander Renberg, B. Stegmayr
S-55-004
An update on assessing and managing Lithium's renal
effects
Jonathan Meyer, USA
aaThursday, 22 June 2017
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-56
08:30–10:00
Clinical effects and neural mechanisms of
electroconvulsive therapy in major depression and
schizophrenia
Chair: Robert Christian Wolf, Germany
Co-Chair: Philipp Thomann, Germany
S-56-001
ECT in major depression and schizophrenia: Indications
and clinical effects
Dusan Hirjak, Germany
S-56-002
Effects of ECT on brain structure and function: Lessons
from major depressive disorder
Robert Christian Wolf, Germany
S-56-003
ECT-related effects on regional brain volume and struc-
tural networks in patients with schizophrenia and major
depressive disorder
Philipp Thomann, Germany
S-56-004
Modulation of intrinsic network connectivity by ECT
in patients with schizophrenia and major depressive
disorder
Fabio Sambataro, Italy
T6: BIPOLAR DISORDERS: BASIC/CLINICAL
S-57
08:30–10:00
Causes and consequences of inflammation in Bipolar
Disorder (BP)
Chair: Lars Kessing, Denmark
Co-Chair: Flavio Kapczinski, Brazil
S-57-001
Peripheral inflammation in Bipolar Disorder (BP): Trait
and state related alterations
Klaus Munkholm, Denmark
S-57-002
Targeting mitochondrial inflammation in Bipolar Disorder
(BP)
Ana Andreazza, Canada
S-57-003
Relationships between inflammation, elevated body
mass index, and depressive relapse in Bipolar Disorder
(BP)
David Bond, USA
WED THU